Cargando…

Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood

We conducted a 5-year study analyzing antibody and B cell responses to the influenza A virus components of the inactivated influenza vaccine, trivalent (IIV3) or quadrivalent (IIV4) in younger (aged 35-45) and aged (≥65 years of age) Caucasian and African American individuals. Antibody titers to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurupati, Raj, Kossenkov, Andrew, Haut, Larissa, Kannan, Senthil, Xiang, Zhiquan, Li, Yan, Doyle, Susan, Liu, Qin, Schmader, Kenneth, Showe, Louise, Ertl, Hildegund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325335/ https://www.ncbi.nlm.nih.gov/pubmed/27588486 http://dx.doi.org/10.18632/oncotarget.11704

Ejemplares similares

A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged
por: Kannan, Senthil, et al.
Publicado: (2015)

Immune response to influenza vaccination in the elderly is altered by chronic medication use
por: Agarwal, Divyansh, et al.
Publicado: (2018)

B cell responses to the 2011/12-influenza vaccine in the aged
por: Kurupati, Raj K., et al.
Publicado: (2013)

BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine
por: Kannan, Senthil, et al.
Publicado: (2015)

Age-related changes in B cell metabolism
por: Kurupati, Raj K., et al.
Publicado: (2019)

Vaccine-Induced Boosting of Influenza Virus-Specific CD4 T Cells in Younger and Aged Humans
por: Dolfi, Douglas V., et al.
Publicado: (2013)

Age-related changes in the transcriptome of antibody-secreting cells
por: Kannan, Senthil, et al.
Publicado: (2016)

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
por: Kurupati, Raj K., et al.
Publicado: (2018)

Vaccine-induced ICOS(+)CD38(+) circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways
por: Herati, Ramin Sedaghat, et al.
Publicado: (2021)

Coaching tumor-infiltrating CD8+ T cells to eat right
por: Kurupati, Raj, et al.
Publicado: (2018)

Pandemic Influenza Vaccines
por: DiMenna, Lauren J., et al.
Publicado: (2009)

Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination
por: Dawany, Noor, et al.
Publicado: (2016)

Coaching tumor-infiltrating CD8(+) T cells to eat right
por: Kurupati, Ral, et al.
Publicado: (2018)

Novel Vaccines to Human Rabies
por: Ertl, Hildegund C. J.
Publicado: (2009)

New Rabies Vaccines for Use in Humans
por: Ertl, Hildegund C. J.
Publicado: (2019)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013
por: Cobey, Sarah, et al.
Publicado: (2018)

Correlates of Protection Against SIV(mac251) Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
por: Tuyishime, Steven, et al.
Publicado: (2018)

New human rabies vaccines in the pipeline
por: Fooks, Anthony R., et al.
Publicado: (2019)

The peripheral immune response and lung cancer prognosis
por: Showe, Michael K., et al.
Publicado: (2012)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
por: Carregaro, Rodrigo Luiz, et al.
Publicado: (2023)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination
por: He, Xiao-Song, et al.
Publicado: (2015)

Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
por: Ertl, Hildegund C. J., et al.
Publicado: (2022)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health
por: Ertl, Hildegund C. J., et al.
Publicado: (2022)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
por: Schmader, Kenneth E., et al.
Publicado: (2023)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Update of inactivated equine influenza vaccine strain in Japan
por: GAMOH, Koichiro, et al.
Publicado: (2017)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
por: Murdoch, Louise, et al.
Publicado: (2023)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
por: Herrera-Rodriguez, José, et al.
Publicado: (2019)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Quantitative review of antibody response to inactivated seasonal influenza vaccines
por: Seidman, Jessica C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_menkva8kkqknm7d13fkevrc6gq